AgingResearch.NewsJoin free

ModernaTX

Part of Moderna

CompanyUnited StatesFounded 2009

ModernaTX develops 4 assets, the furthest approved (elasomeran in COVID-19). Mostly mrna and vaccine acting on S; based in the United States, founded in 2009.

4
Assets
Furthest stage
Approved
18
Trials
7
Signals

Pipeline

4

  • elasomeran

    Encodes SARS-CoV-2 spike protein to induce protective immune responses against COVID-19.

    Approved, mRNA, S, COVID-19, sars cov 2 (Phase 3)

  • intismeran autogene

    Individualized neoantigen mRNA vaccine stimulating tumor-specific T-cell immune responses against melanoma.

    Phase 3, mRNA, cancer, melanoma, Partner

  • Spikevax

    Lipid nanoparticle-delivered mRNA encodes SARS-CoV-2 spike protein to induce protective immunity.

    Phase 3, Vaccine, sars cov 2

1 more asset

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms4
  • Trials30
  • Signals17
  • Similar companies6

Intelligence